AXNX vs AHCO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AHCO Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to AdaptHealth Corp. Common Stock (AHCO) driven by superior Valuation, Growth & Margin, Options & Structure while AXNX counters with relative strength in Momentum & Technical. Fundamentally, AXNX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AHCO at 7.8x Forward P/E and 3.8% operating margin (+10.9% YoY). In options structure, AXNX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AHCO sits in SURGE (12th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AXNX | AHCO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $989.8M | Larger Scale | AHCO |
| Trailing P/E Ratio Valuation | N/M | 7.8x | Lower Multiple | AHCO |
| Forward P/E Ratio Valuation | N/M | 7.8x | Lower Multiple | AHCO |
| Revenue Growth (YoY) Growth | N/A | +10.9% | Higher Growth | AHCO |
| Operating Margin (TTM) Profitability | N/A | 3.8% | Higher Margin | AHCO |
| Net Profit Margin Profitability | N/A | -11.8% | Higher Margin | AHCO |
| Return on Equity (ROE) Capital Efficiency | N/A | -28.4% | Higher ROE | AHCO |
| 52-Week Range Position Momentum | 50% ($0โ$1) | 24% ($5โ$13) | Stronger Trend | AXNX |
| Beta / 30D Volatility Risk Regime | N/A | 0.17ฮฒ ยท 67% Vol | Lower Realized Risk | AHCO |
| Unified Institutional Score Composite Signal | 52.1 / 100 (HOLD) | 45.2 / 100 (HOLD) | Higher Composite | AXNX |